Opportunities and challenges of a novel cardiac output response to stress (CORS) test to enhance diagnosis of heart failure in primary care: qualitative study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
14 04 2019
Historique:
entrez: 17 4 2019
pubmed: 17 4 2019
medline: 18 4 2020
Statut: epublish

Résumé

To explore the role of the novel cardiac output response to stress (CORS), test in the current diagnostic pathway for heart failure and the opportunities and challenges to potential implementation in primary care. Qualitative study using semistructured in-depth interviews which were audio recorded and transcribed verbatim. Data from the interviews were analysed thematically using an inductive approach. Newcastle upon Tyne, UK. Fourteen healthcare professionals (six males, eight females) from primary (general practitioners (GPs), nurses, healthcare assistant, practice managers) and secondary care (consultant cardiologists). Four themes relating to opportunities and challenges surrounding the implementation of the new diagnostic technology were identified. These reflected that the adoption of CORS test would be an advantage to primary care but the test had barriers to implementation which include: establishment of clinical utility, suitability for immobile patients and cost implication to GP practices. The development of a simple non-invasive clinical test to accelerate the diagnosis of heart failure in primary care maybe helpful to reduce unnecessary referrals to secondary care. The CORS test has the potential to serve this purpose; however, factors such as cost effectiveness, diagnostic accuracy and seamless implementation in primary care have to be fully explored.

Identifiants

pubmed: 30987993
pii: bmjopen-2018-028122
doi: 10.1136/bmjopen-2018-028122
pmc: PMC6500186
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e028122

Subventions

Organisme : Medical Research Council
ID : MC_PC_15030
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K02325X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : BH161161
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ. 2003 Jan 25;326(7382):196
pubmed: 12543836
Heart. 2010 Nov;96(21):1773-7
pubmed: 20956495
BMJ Open. 2018 Oct 25;8(10):e024558
pubmed: 30366918
Br J Gen Pract. 2010 Mar;60(572):e98-104
pubmed: 20202351
ESC Heart Fail. 2018 Aug;5(4):703-712
pubmed: 29943902
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
BMJ. 2000 Jan 1;320(7226):50-2
pubmed: 10617534
Eur Heart J. 2002 Dec;23(23):1867-76
pubmed: 12445536
Eur J Heart Fail. 2012 Sep;14(9):1000-8
pubmed: 22713289
Br J Gen Pract. 2017 Jul;67(660):326-327
pubmed: 28663432
Ups J Med Sci. 2015 Mar;120(1):1-10
pubmed: 25622619
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
BMJ. 2015 Mar 04;350:h910
pubmed: 25740799
Heart Fail Rev. 2006 Jun;11(2):95-107
pubmed: 16937029
BJGP Open. 2017 Nov 15;1(4):bjgpopen17X101229
pubmed: 30564692
Circulation. 2011 Dec 20;124(25):2865-73
pubmed: 22104551
BMC Fam Pract. 2019 Jan 10;20(1):8
pubmed: 30630430
Br J Gen Pract. 2017 Feb;67(655):e94-e102
pubmed: 27919937
Br J Gen Pract. 2011 Feb;61(583):139-40
pubmed: 21276342
Int J Clin Pract. 2015 Nov;69(11):1349-56
pubmed: 26194330
Eur J Heart Fail. 2004 Aug;6(5):571-6
pubmed: 15352303

Auteurs

Sarah Charman (S)

Cardiovascular Research Centre, Newcastle University, Newcastle, UK.

Nduka Okwose (N)

Cardiovascular Research Centre, Newcastle University, Newcastle, UK.

Gregory Maniatopoulos (G)

Institute of Health and Society, Newcastle University, Newcastle, UK.

Sara Graziadio (S)

NIHR In Vitro Diagnostics Co-operative, Newcastle University, Newcastle, UK.

Tamara Metzler (T)

Cardiovascular Research Centre, Newcastle University, Newcastle, UK.

Helen Banks (H)

Cardiovascular Research Centre, Newcastle University, Newcastle, UK.

Luke Vale (L)

Health Economics Group, Institute of Health and Society, Newcastle University, Newcastle, UK.

Guy A MacGowan (GA)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, Tyne and Wear, UK.

Petar M Seferović (PM)

Cardiology, University of Belgrade School of Medicine, Belgrade, Serbia.

Ahmet Fuat (A)

Primary Care, Carmel Medical Practice, Darlington, UK.

Christi Deaton (C)

Cambridge Institute of Public Health, School of Clinical Medicine, University of Cambridge, Cambridge, UK.

Jonathan Mant (J)

General Practice and Primary Care Research Unit, University of Cambridge, Cambridge, UK.

Richard F D Hobbs (RFD)

Department of Primary Health Care, University of Oxford, Oxford, UK.

Djordje G Jakovljevic (DG)

Institute for Ageing and Health, Newcastle University, Newcastle, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH